SCHEMBL19852605

SCHEMBL19852605

CN1C(=O)c2cccc(-n3c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4c4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc43)c2C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 1/20 0.45
▸ MAOA P21397 1/20 0.36
▸ CASP3 P42574 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TTR P02766 1/20 0.35
▸ CES1 P23141 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ BRCA1 P38398 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPK14 Q16539 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ TYMS P04818 1/20 0.34
▸ BRD4 O60885 2/20 0.34
▸ HPGD P15428 1/20 0.33
▸ PDE6D O43924 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19848821 0.97 ADK (0.43) ADKMAOACASP3MAPTMAPK14
SCHEMBL23516093 0.91 ADK (0.45) ADKMAOACASP3MAPTTTR
SCHEMBL23516088 0.90 ADK (0.43) ADKMAOACASP3MAPTTTR
SCHEMBL19848810 0.85 NR1H2 (0.45) CES1MEN1KMT2AALDH1A1GAA
SCHEMBL23516107 0.85 HSPA1A (0.44) MAPTCES1MEN1USP2KMT2A
SCHEMBL23516167 0.84 ADK (0.43) ADKCASP3MAPTTTRCES1
SCHEMBL23516294 0.84 PDE6D (0.47) MAPTCES1MEN1USP2KMT2A
SCHEMBL19848962 0.84 ADK (0.45) ADKCASP3MAPTTTRCES1
SCHEMBL23516168 0.84 ADK (0.47) ADKMAOACASP3MAPTTTR
SCHEMBL19843486 0.84 TYMS (0.39) MEN1KMT2AALDH1A1TYMSHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed
EP-3279193-B1 COMPOUNDS COMPRISING A PHTHALIMIDE GROUP AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-05-08 — — EP disclosed
WO-2018024723-A1 PHTHALIMIDE AND CARBAZOLE OR ANALOGS THEREOF CONTAINING COMPOUNDS FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L ADK 3537/4885MAOA 175/4885CASP3 2113/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM ADK 3298/4885MAOA 84/4885CASP3 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback